Chlamydia trachomatis pmpA Gene Detection via PCR Oligonucleotides
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current diagnostic methods for Chlamydia trachomatis face challenges such as false-negative results due to strains lacking the cryptic plasmid and interference in multiplex DNA amplification reactions, as well as inefficient DNA extraction processes, which hinder accurate and rapid detection.
Innovation Solution
The use of oligonucleotides targeting the pmpA gene, specifically designed for PCR and real-time PCR assays, with a lysis buffer containing non-ionic detergents like Tween-20, allows for accurate amplification and detection of C. trachomatis in clinical samples without interference, enabling simultaneous detection of multiple genes in a single assay.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If assays target the cryptic plasmid for detecting C. trachomatis, then detection sensitivity is improved, but false-negative results occur in strains lacking the plasmid or with deletions
Solution Approach 1:
The patent divides the detection target into multiple independent genetic markers (cryptic plasmid and pmpA gene) instead of relying on a single target. This segmentation ensures that if one target is absent or mutated, the other can still provide accurate detection, thereby reducing false-negative results while maintaining high detection sensitivity.
2Productivity
If multiplex DNA amplification reactions are used to detect multiple genes, then screening efficiency is improved, but reagent cross-reactivity and interference occur
Solution Approach 1:
The patent applies local quality by designing multiplex assays with distinct, non-interfering reagent systems for each pathogen detection. Each amplification reaction uses specifically tailored primers, probes, and conditions that are optimized for its target, preventing cross-reactivity while maintaining high throughput capability.
Solution Approach 2:
The multiplex assay is segmented into separate, independently optimized reaction channels for different pathogens. This allows simultaneous detection of multiple genes without reagent interference, as each channel operates with its own dedicated reagents and parameters.
3Manufacturing precision
If traditional DNA extraction methods are used, then DNA purification is achieved, but extraction time is prolonged and reagents interfere with downstream amplification
Solution Approach 1:
The patent merges the DNA extraction step with the amplification reaction by using a lysis buffer that is compatible with downstream PCR. This combination eliminates the need for separate extraction and purification steps, significantly reducing total assay time while maintaining DNA quality suitable for amplification.
Solution Approach 2:
The patent extracts DNA using a specialized lysis buffer formulated to be PCR-compatible, removing the need for traditional multi-step extraction protocols. This selective extraction approach obtains sufficient DNA directly in a form ready for amplification, eliminating time-consuming purification steps.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach provides a reliable and efficient method for detecting C. trachomatis, minimizing false negatives and streamlining the DNA extraction process, while allowing for the detection of multiple pathogens in a single assay without cross-reactivity.
Implementation Method 1
a lysis buffer containing non-ionic detergents like Tween-20, allows for accurate amplification and detection of C. trachomatis
Implementation Method 2
The use of oligonucleotides targeting the pmpA gene, specifically designed for PCR and real-time PCR assays, allows for accurate amplification and detection
Implementation Method 3
amplification and detection of C. trachomatis PMPA gene
Data Source
AI summary
A region of the Chlamydia trachomatis pmpA gene has been identified which is useful for performing amplification assays to determine specifically whether C. trachomatis is present in the sample being tested. Oligonucleotides useful for detecting this gene by performing the polymerase chain reaction (PCR) are disclosed. The disclosed oligonucleotides can be used in an assay which is specific for multiple strains or serovars of C. trachomatis, including the variant E serovar, and which does not show cross reactivity with the genomes of other microorganisms or with human DNA. In addition, the disclosed oligonucleotides can be used to in a multiplex system. This invention also contemplates a kit including oligonucleotides, and optionally other reagents, for the detection of C. trachomatis using PCR.